Organisation Australasian Leukaemia and Lymphoma Group (ALLG) Health Data Australia Contributor Records Viewed: [[ro.stat.viewed]] Click to explore relationships graph Help Related Data $relation_to_title = []; $dupes = 0;?> Funds, Makes available 5-azacitidine and Thalidomide for patients with Myelodysplastic Syndromes to assess safety and efficacy (MDS03) Funds, Makes available A Multicentre Phase 3 Trial Comparing Elotuzumab-Cyclophosphamide-Thalidomide-Dexamethasone (E-CTD) with Cyclophosphamide-Thalidomide-Dexamethasone (CTD) for the Treatment of Relapsed and/or Refractory Multiple Myeloma (RRMM) (MM20) Funds, Makes available A Multicentre Randomised Controlled Trial Comparing Two Strategies for the Diagnosis of Invasive Aspergillosis in High-Risk Haematology Patients (SC01) Funds, Makes available A Phase II Pilot Study of Glivec (imatinib mesylate formerly known as STI571) Combined with Induction Chemotherapy in Blast-Phase Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia, to evaluate safety and improve remission rate.(CMLALL01) Funds, Makes available A Phase II Study of Dasatinib Combined with Induction Chemotherapy in Previously Untreated de novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia to Assess Safety and Tolerability (ALL05) View all 32 related data User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover Identifiers ROR : ror.org/05t72y326 Saved to MyRDA Save to MyRDA
Click to explore relationships graph Help Related Data $relation_to_title = []; $dupes = 0;?> Funds, Makes available 5-azacitidine and Thalidomide for patients with Myelodysplastic Syndromes to assess safety and efficacy (MDS03) Funds, Makes available A Multicentre Phase 3 Trial Comparing Elotuzumab-Cyclophosphamide-Thalidomide-Dexamethasone (E-CTD) with Cyclophosphamide-Thalidomide-Dexamethasone (CTD) for the Treatment of Relapsed and/or Refractory Multiple Myeloma (RRMM) (MM20) Funds, Makes available A Multicentre Randomised Controlled Trial Comparing Two Strategies for the Diagnosis of Invasive Aspergillosis in High-Risk Haematology Patients (SC01) Funds, Makes available A Phase II Pilot Study of Glivec (imatinib mesylate formerly known as STI571) Combined with Induction Chemotherapy in Blast-Phase Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia, to evaluate safety and improve remission rate.(CMLALL01) Funds, Makes available A Phase II Study of Dasatinib Combined with Induction Chemotherapy in Previously Untreated de novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia to Assess Safety and Tolerability (ALL05) View all 32 related data User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover Identifiers ROR : ror.org/05t72y326